Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000710645 | SCV000840893 | pathogenic | not provided | 2018-02-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000710645 | SCV003459829 | pathogenic | not provided | 2022-06-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 585449). This sequence change creates a premature translational stop signal (p.Arg2442*) in the ASPM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASPM are known to be pathogenic (PMID: 19028728, 23611254). This variant is present in population databases (rs769364943, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with clinical features of primary microcephaly (PMID: 29388391). |
Genome- |
RCV003453512 | SCV004177607 | pathogenic | Microcephaly 5, primary, autosomal recessive | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genetics and Genomic Medicine Centre, |
RCV003453512 | SCV005873756 | likely pathogenic | Microcephaly 5, primary, autosomal recessive | 2022-09-29 | criteria provided, single submitter | clinical testing |